Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...
Chinese Cancer Drug Developer Hutchmed Sharpens R&D Focus, Divests Non-Core JV For Over $600 Million
On Wednesday, Hutchmed (China) Limited (NASDAQ:HCM) entered into two agreements to divest its 45% equity interest in Shanghai Hutchison Pharmaceuticals Limited (SHPL) for approximately $608 million ...
HUTCHMED has announced its decision to divest its 45% equity interest in Shanghai Hutchison Pharmaceuticals Limited for approximately $608 million, a move that aligns with its strategic goal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback